OMGA 1.43 (+5.15%)
US68217N1054BiotechnologyBiotechnology

Omega Therapeutics (OMGA) Stock Highlights

1.43 | +5.15%
2024-09-19 06:18:39
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. It primarily operates in the U.S.

Statistics

Range Today
1.35 1.5
Volume Today 292.8K
Range 1 Year
1.22 6.3
Volume 1 Year 196.62M
Range 3 Year
1.22 31.41
Volume 3 Year 253.53M
Range 10 Year
1.22 31.41
Volume 10 Year 259.44M

Highlights

Market Capitalization 73.36M (small)
Floating Shares 21.33M
Current Price 1.43
Price To Earnings -0.93
Price To Revenue 23.68
Price To Book 2.79
Earnings Per Share -1.42
Payout Ratio 0%

Performance

Latest +5.15%
1 Month -4.67%
3 Months -30.24%
6 Months -61.04%
1 Year -57.19%
3 Years -93.45%
5 Years -93.14%
10 Years -93.14%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.